
Tiplaxtinin New

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 393105-53-8 | Cat. No. | BCP02216 |
Name | Tiplaxtinin | ||
Synonyms | PAI-039;PAI 039;PAI039; | ||
SMILES | O=C(O)C(C1=CN(CC2=CC=CC=C2)C3=C1C=C(C4=CC=C(OC(F)(F)F)C=C4)C=C3)=O | ||
Chemical Name | |||
Formula | C24H16F3NO4 | M. Wt | 439.38 |
Purity | 98% | Storage | Store at 4-8°C |
Description | Tiplaxtinin, also known as PAI-039, is a novel plasminogen activator inhibitor-1 (PAI-1) inhibitor. The pharmacokinetic profile of PAI-039 indicated an oral bioavailability of 43 +/- 15.3% and a plasma half-life of 6.2 +/- 1.3 h. PAI-039 is an orally active prothrombolytic drug that inhibits PAI-1 and accelerates fibrinolysis while maintaining normal coagulation in a model of coronary occlusion . PAI-039 exerts antithrombotic efficacy in rat models of arterial and venous vascular injury without effecting platelet aggregation. PAI-039 as a novel therapeutic may improve diabetic wound closure. |
Recommend Products
More >Tags:Tiplaxtinin supplier,Tiplaxtinin purchase,Tiplaxtinin manufacturer,Tiplaxtinin distributor,Tiplaxtinin cost,Tiplaxtinin buy,Tiplaxtinin for sale